These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 24982232
1. Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. Gentile I, Zappulo E, Bonavolta R, Maresca R, Messana T, Buonomo AR, Portella G, Sorrentino R, Settimi A, Pascotto A, Borgia G, Bravaccio C. In Vivo; 2014; 28(4):621-6. PubMed ID: 24982232 [Abstract] [Full Text] [Related]
2. Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder. Valayi S, Eftekharian MM, Taheri M, Alikhani MY. Hum Antibodies; 2017; 26(3):165-169. PubMed ID: 29689713 [Abstract] [Full Text] [Related]
3. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP, Buonomo AR, Portella G, Vallefuoco L, Settimi A, Pascotto A, Borgia G, Bravaccio C. In Vivo; 2014; 28(4):667-71. PubMed ID: 24982239 [Abstract] [Full Text] [Related]
4. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovitch N, Huerta-Hartal M, Ankol OE. Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994 [Abstract] [Full Text] [Related]
5. Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP, Buonomo AR, Portella G, Settimi A, Pascotto A, Borgia G, Bravaccio C. In Vivo; 2014 Nov; 28(4):627-31. PubMed ID: 24982233 [Abstract] [Full Text] [Related]
6. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K. J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683 [Abstract] [Full Text] [Related]
7. Prevalence of HHV-6 and HHV-8 antibodies in patients with autism spectrum disorders. Gentile I, Zappulo E, Coppola N, Bonavolta R, Portella G, Cernia DS, Riccio MP, Settimi A, Pascotto A, Borgia G, Bravaccio C. In Vivo; 2013 Nov; 27(6):843-9. PubMed ID: 24292591 [Abstract] [Full Text] [Related]
8. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran? Saghafi H, Qorashi M, Heidari A. Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428 [Abstract] [Full Text] [Related]
9. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase. Nagy J, Haikin H, Sarov B, Háber A, Kun L, Sarov I. Acta Microbiol Immunol Hung; 1995 Sep; 42(2):179-87. PubMed ID: 7551711 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus and cytomegalovirus are differentially associated with numbers of cytokine-producing cells and early atopy. Nilsson C, Larsson Sigfrinius AK, Montgomery SM, Sverremark-Ekström E, Linde A, Lilja G, Blomberg MT. Clin Exp Allergy; 2009 Apr; 39(4):509-17. PubMed ID: 19055650 [Abstract] [Full Text] [Related]
11. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056 [Abstract] [Full Text] [Related]
12. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. BMC Infect Dis; 2008 Aug 18; 8():111. PubMed ID: 18706107 [Abstract] [Full Text] [Related]
13. [CMC and EBV infections in children]. Polz-Dacewicz M, Stec A, Koncewicz R. Przegl Epidemiol; 2002 Aug 18; 56(1):65-72. PubMed ID: 12150069 [Abstract] [Full Text] [Related]
14. Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder. Shi Z, Kong L, Wang R, Wang X, Wang Z, Luo W, Chen H, Du Q, Sun D, Zhou H. J Neurol; 2024 Sep 18; 271(9):6089-6095. PubMed ID: 39046523 [Abstract] [Full Text] [Related]
15. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV. Tcherniaeva I, den Hartog G, Berbers G, van der Klis F. J Immunol Methods; 2018 Nov 18; 462():1-8. PubMed ID: 30056034 [Abstract] [Full Text] [Related]
16. Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients. Ramirez-Avila L, Garner OB, Cherry JD. Pediatr Transplant; 2014 Sep 18; 18(6):599-601. PubMed ID: 25041939 [Abstract] [Full Text] [Related]
18. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease. deBruyn JCC, Soon IS, Fonseca K, Feng S, Purtzki M, Goedhart C, Kuhn S, Vanderkooi OG, Wrobel I. Inflamm Bowel Dis; 2019 Jun 18; 25(7):1218-1226. PubMed ID: 30551205 [Abstract] [Full Text] [Related]
19. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B. J Immunol Methods; 2014 Jun 18; 408():101-13. PubMed ID: 24877879 [Abstract] [Full Text] [Related]
20. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases. Ferrari de Freitas L, de Melo Silva J, Nogueira Barbosa A, Miranda Santos E, Pinheiro-Silva R, Soares Pontes G. Biomolecules; 2021 Aug 04; 11(8):. PubMed ID: 34439817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]